What motivates patients to report an adverse drug reaction?

Annals of Pharmacotherapy

Volumn 44, Issue 5, 2010, Pages 936-937

  Van Hunsel, Florence Pam ^a,b   Ten Berge, Elaine Aam ^c   Borgsteede, Sander D ^a   Van Grootheest, Kees ^b  

^a NETHERLANDS PHARMACOVIGILANCE CENTRE LAREB   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARDIOVASCULAR AGENT;

ADVERSE DRUG REACTION; DRUG SURVEILLANCE PROGRAM; HUMAN; LETTER; PATIENT CARE; PRIORITY JOURNAL; SELF REPORT; SEMI STRUCTURED INTERVIEW;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTI-BACTERIAL AGENTS; CARDIOVASCULAR AGENTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MOTIVATION; PATIENTS; QUESTIONNAIRES;

EID: 77951520799     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M632     Document Type: Letter

References (5)

1. Harmark L, van Grootheest AC. Pharmacovigilance: methods, recent developments and future perspectives. Eur J Clin Pharmacol 2008;64:743-752 DOI 10.1007/s00228-008-0475-9
2. van Grootheest K, de Jong-van den Berg L. Patients' role in reporting adverse drug reactions. Expert Opin Drug Saf 2004;3:363-368 (Pubitemid 39023084)
3. de Langen J, van Hunsel F, Passier A, de Jong-van den Berg L, van Grootheest K. Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf 2008;31:515-524 DOI 10.2165/00002018- 200831060-00006
4. Kuper A, Lingard L, Levinson W. Critically appraising qualitative research. BMJ 2008;337:a1035. DOI 10.1136/bmj.a1035
5. Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther 2005;85:257-268 (Pubitemid 40333545)